About The Medical Condition Drug Evaluation, FDA Phase 4
Find the definition of the medical term Drug Evaluation, FDA Phase 4. Drug Evaluation, FDA Phase 4 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase 4
| Drug Evaluation, FDA Phase 4 Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase 4?
Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Diabetic Polyneuropathies ‐ Peripheral, autonomic, and cranial nerve disorders that are associated…
- Proteins, v-rel ‐ Transforming proteins coded by rel oncogenes. The v-rel protein…
- Sulbenicillin ‐ Semisynthetic penicillin-type…
- Anal Sacs ‐ Two sacs opening on either side of the anus near the junction…
- Chard ‐ A species of the Beta genus. Cultivars are used as a source of…
- Disease, Hereditary Neurodegenerative ‐ Inherited disorders characterized by progressive atrophy and…
- Antischistosomal Agents ‐ Agents that act systemically to kill adult…
- Tactile Reflex Epilepsies ‐ A subtype of epilepsy characterized by seizures that are consistently…
- Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor ‐ Ordered rearrangement of T-cell variable gene regions coding…
- Somnolence Disorders, Excessive ‐ Disorders characterized by hypersomnolence during normal waking…